Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Acorda Therapeutics (ACOR)
NASDAQ:ACOR
Acorda Therapeutics (ACOR) Financial Statements
586 Followers
Acorda Therapeutics Financial Overview
| Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 22.26M | $ 31.47M | $ 33.51M | $ 31.05M | $ 22.53M |
| Gross Profit | $ 19.02M | $ 39.46M | $ 22.51M | $ 22.25M | $ 16.57M |
| EBIT | $ -11.38M | $ 27.40M | $ -4.97M | $ -12.64M | $ -16.70M |
| EBITDA | $ -3.69M | $ 35.09M | $ 2.82M | $ -4.20M | $ -8.17M |
| Net Income Common Stockholders | $ -16.82M | $ 19.14M | $ -13.85M | $ -46.68M | $ -24.52M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 37.24M | $ 44.42M | $ 20.70M | $ 23.13M | $ 31.87M |
| Total Assets | $ 372.52M | $ 395.60M | $ 393.34M | $ 406.31M | $ 424.14M |
| Total Debt | $ 177.11M | $ 172.92M | $ 193.75M | $ 191.22M | $ 193.34M |
| Net Debt | $ 139.86M | $ 128.50M | $ 173.06M | $ 168.09M | $ 161.47M |
| Total Liabilities | $ 297.95M | $ 301.97M | $ 317.57M | $ 318.40M | $ 296.59M |
| Stockholders Equity | $ 76.96M | $ 93.62M | $ 75.77M | $ 87.91M | $ 127.55M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -7.02M | $ 9.19M | $ -1.99M | $ -14.58M | $ -13.68M |
| Operating Cash Flow | $ -7.02M | $ 9.07M | $ -1.84M | $ -14.51M | $ -13.64M |
| Investing Cash Flow | - | $ 123.00K | $ -150.00K | $ -70.00K | $ -39.00K |
| Financing Cash Flow | - | - | $ 0.00 | $ 0.00 | $ 0.00 |